Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a poorer outcome compared with normoglycemic individuals and people with pre-existing diabetes.
Keywords: COVID-19; New-onset diabetes; New-onset hyperglycemia; Outcomes; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.